High frequency of T cells specific for cryptic epitopes in melanoma patients.
A number of cytotoxic T-cell epitopes are cryptic epitopes generated from non-conventional sources. These include epitopes that are encoded by alternative open reading frames or in generally non-coding genomic regions, such as introns. We have previously observed a frequent recognition of cryptic epitopes by tumor infiltrating lymphocytes isolated from melanoma patients. Here, we show that such cryptic epitopes are more frequently recognized than antigens of the same class encoded by canonical reading frames. Furthermore, we report the presence of T cells specific for three cryptic epitopes encoded in intronic sequences, as a result of incomplete splicing, in the circulation of melanoma patients. One of these epitopes derives from antigen isolated from immunoselected melanoma 2 (AIM2), while the two others are encoded in an alternative open reading frame of an incompletely spliced form ofN-acetylglucosaminyl-transferase V (GNT-V) known as NA17-A. We have detected frequent T-cell responses against AIM2 and NA17-A epitopes in the blood of melanoma patients, both prior and after one round of in vitro peptide stimulation, but not in the circulation of healthy individuals and patients with breast or renal carcinoma. In summary, our findings indicate that the T-cell reactivity against AIM2 and NA17-A in the blood of melanoma patients is extensive, suggesting that-similar to melan A (also known as MART1)-these antigens might be used for immunomonitoring or as model antigens in several clinical and preclinical settings.
Center for Cancer Immune Therapy; University Hospital Herlev; Herlev, Denmark.
Rikke Sick
RS
Andersen
Sofie Ramskov
SR
Andersen
Mads Duus
MD
Hjortsø
Rikke
R
Lyngaa
Manja
M
Idorn
Tania Maria
TM
Køllgård
Ozcan
O
Met
Per
P
Thor Straten
Sine Reker
SR
Hadrup
CD8 T cells; T-cell reactivity; antigens; cryptic T-cell epitopes; melanoma